Detection and Characterization of Sessile Serrated Lesions (SSL) of the Right Colon
Launched by HOSPICES CIVILS DE LYON · Aug 9, 2016
Trial Information
Current as of June 18, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female patients 18 years of age or older
- * Patient having an indication for colonoscopy to detect colorectal neoplastic lesions, which meet at least one of the following conditions :
- • Positive fecal occult blood test
- • 1st degree family history of colorectal cancer or adenoma before 60 years of age
- • Personal history of colorectal adenoma or colorectal cancer
- • Unexplained digestive symptoms after 50 years of age or those not responding to symptomatic treatment : modification of bowel movements, abdominal pains
- • Isolated or repeated rectal bleeding after 50 years of age or occult bleeding
- • Acromegaly
- • Infectious endocarditis with digestive bacteria
- • Suspicion of sessile serrated lesion in the right colon
- • None opposite of patient for participating
- Exclusion Criteria:
- • History of digestive resection as resection of the right colon (right ileocolectomy, right hemicolectomy) or large colic resection.
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clermont Ferrand, , France
Lyon Cedex 04, , France
Lyon, , France
Lyon, , France
Pierre Benite, , France
Villefranche Sur Saone, , France
Patients applied
Trial Officials
Christine CHAMBON-AUGOYARD, MD
Principal Investigator
Hospices Civils de Lyon, Hôpital E Herriot, Service d'hépatogastroentérologie, 5 place d'Arsonval, 69437 LYON cedex 03, France
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials